1. EMA concludes Zydelig review, issues recommendations

   News item 23 July 2016 Pages: 1 - 1

2. Lareb reports steroid withdrawal syndrome

   News item 23 July 2016 Pages: 2 - 2

3. Survey volunteers wanted for European Web-RADR project

   News item 23 July 2016 Pages: 3 - 3

4. AHA warns of medications which worsen heart failure

   News item 23 July 2016 Pages: 4 - 4

5. EMA acknowledges outcome of recent UK referendum

   News item 23 July 2016 Pages: 5 - 5

6. Checkpoint inhibitors: costs of managing toxicities similar

   Clinical study 23 July 2016 Pages: 6 - 6

7. High-risk drugs inappropriately prescribed in Canada

   Clinical study 23 July 2016 Pages: 7 - 7

8. Important differences between antidiabetic drugs

   Clinical study 23 July 2016 Pages: 8 - 8

9. Large physician visit numbers for subsequently withdrawn drugs

   Clinical study 23 July 2016 Pages: 9 - 9

10. Off-label and unlicensed drug use high in infants in Lebanon

    Clinical study 23 July 2016 Pages: 10 - 10

11. Pharmacist interventions have cost-benefit and prevent AEs

    Clinical study 23 July 2016 Pages: 11 - 11

12. Sulfonylureas associated with hypoglycaemia

    Clinical study 23 July 2016 Pages: 12 - 12

13. Transdermal estrogen: less CVD events and lower costs

    Clinical study 23 July 2016 Pages: 13 - 13

14. ACE-inhibitors/racecadotril

    Case report 23 July 2016 Pages: 14 - 14

15. Aciclovir

    Case report 23 July 2016 Pages: 15 - 15

16. Adefovir dipivoxil

    Case report 23 July 2016 Pages: 16 - 16

17. Alendronic acid

    Case report 23 July 2016 Pages: 17 - 17

18. Allopurinol

    Case report 23 July 2016 Pages: 18 - 18

19. Amiodarone

    Case report 23 July 2016 Pages: 19 - 19

20. Amiodarone

    Case report 23 July 2016 Pages: 20 - 20

21. Antiarrhythmics/aspirin

    Case report 23 July 2016 Pages: 21 - 21

22. Antineoplastic drugs

    Case report 23 July 2016 Pages: 22 - 22

23. Antineoplastics

    Case report 23 July 2016 Pages: 23 - 23

24. Antineoplastics

    Case report 23 July 2016 Pages: 24 - 24

25. Antiretrovirals/tacrolimus interaction

    Case report 23 July 2016 Pages: 25 - 25

26. Antivirals

    Case report 23 July 2016 Pages: 26 - 26

27. Apixaban/rivaroxaban

    Case report 23 July 2016 Pages: 27 - 27

28. Aripiprazole

    Case report 23 July 2016 Pages: 28 - 28

29. Ascorbic-acid/gefitinib

    Case report 23 July 2016 Pages: 29 - 29

30. Aspirin/phenobarbital

    Case report 23 July 2016 Pages: 30 - 30

31. Atorvastatin

    Case report 23 July 2016 Pages: 31 - 31

32. Atorvastatin

    Case report 23 July 2016 Pages: 32 - 32

33. Atorvastatin/sitagliptin interaction

    Case report 23 July 2016 Pages: 33 - 33

34. Azathioprine

    Case report 23 July 2016 Pages: 34 - 34

35. BCG

    Case report 23 July 2016 Pages: 35 - 35

36. BCG vaccine

    Case report 23 July 2016 Pages: 36 - 36

37. Bcg-vaccine

    Case report 23 July 2016 Pages: 37 - 37

38. Bexarotene

    Case report 23 July 2016 Pages: 38 - 38

39. Bleomycin

    Case report 23 July 2016 Pages: 39 - 39

40. Budesonide/ritonavir interaction

    Case report 23 July 2016 Pages: 40 - 40

41. Busulfan/cyclophosphamide/cytarabine

    Case report 23 July 2016 Pages: 41 - 41

42. Cabergoline

    Case report 23 July 2016 Pages: 42 - 42

43. Cabergoline

    Case report 23 July 2016 Pages: 43 - 43

44. Carbidopa/levodopa/pramipexole

    Case report 23 July 2016 Pages: 44 - 44

45. Carvedilol/Prednisone

    Case report 23 July 2016 Pages: 45 - 45

46. Catumaxomab/paracetamol

    Case report 23 July 2016 Pages: 46 - 46

47. Celecoxib/erlotinib/methotrexate

    Case report 23 July 2016 Pages: 47 - 47

48. Cetuximab

    Case report 23 July 2016 Pages: 48 - 48

49. Cetuximab/fluorouracil

    Case report 23 July 2016 Pages: 49 - 49

50. Chlorhexidine

    Case report 23 July 2016 Pages: 50 - 50